Rigel Pharmaceuticals (RIGL) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Rigel Pharmaceuticals (RIGL) over the last 10 years, with Q3 2025 value amounting to $1.46.
- Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) rose 10857.14% to $1.46 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.18, marking a year-over-year increase of 270909.09%. This contributed to the annual value of $0.99 for FY2024, which is 16857.67% up from last year.
- As of Q3 2025, Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $1.46, which was up 10857.14% from $3.28 recorded in Q2 2025.
- Rigel Pharmaceuticals' EPS (Weighted Average and Diluted)'s 5-year high stood at $3.28 during Q2 2025, with a 5-year trough of -$0.47 in Q1 2024.
- In the last 5 years, Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.08 in 2021 and averaged $0.27.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 48750.0% in 2024, then surged by 556666.67% in 2025.
- Over the past 5 years, Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.14 in 2021, then skyrocketed by 158.7% to $0.08 in 2022, then plummeted by 39.15% to $0.05 in 2023, then soared by 1519.49% to $0.81 in 2024, then soared by 80.3% to $1.46 in 2025.
- Its last three reported values are $1.46 in Q3 2025, $3.28 for Q2 2025, and $0.63 during Q1 2025.